Director/PDMR Shareholding

RNS Number : 4785G

Arix Bioscience Plc

30 May 2017

 

ARIX BIOSCIENCE PLC

Director/PDMR Shareholding

LONDON, 30 May 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical innovation, announces that awards of shares have been made to several key members of its leadership team under the Company's Long Term Incentive Plan ("LTIP").

Awards of nil cost options have been made to Joseph Anderson, Chief Executive Officer, and James Rawlingson, Chief Financial Officer; a conditional share award has been made to Jonathan Peacock, Chairman.

These will be exercisable in three years' time, subject to the rules of the LTIP and to performance conditions relating to the growth of the Company's share price.  Details of the maximum awards possible are set out below in the PDMR Dealing Notification Forms.

PDMR Dealing Notifications

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Joseph Anderson
2	Reason for the notification
a)	Position / status	Chief Executive Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Long-term Incentive Plan ("LTIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	569,619
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A	N/A
e)	Date of the transaction	26 May 2017
f)	Place of the transaction	Outside of a trading venue

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jonathan Peacock
2	Reason for the notification
a)	Position / status	Chairman
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Conditional share award under the Arix Bioscience plc Long-term Incentive Plan ("LTIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	379,746
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A	N/A
e)	Date of the transaction	26 May 2017
f)	Place of the transaction	Outside of a trading venue

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	James Hedley Rawlingson
2	Reason for the notification
a)	Position / status	Chief Financial Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Long-term Incentive Plan ("LTIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	205,062
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A	N/A
e)	Date of the transaction	26 May 2017
f)	Place of the transaction	Outside of a trading venue

For further information:

James Rawlingson                           Chief Financial Officer                [phone]

 - Ends -

 

END

 

 

DSHFKLLLDEFFBBB